RELATIONAL PARENTING THERAPY FOR OPIOID ABUSING MOTHERS

描述：(申请人摘要) 拟议的研究将涉及一项随机临床试验 关系育儿母亲小组(RPMG)，一种旨在 孩子不到14岁的阿片类药物滥用妇女，这是 作为第一阶段研究的一部分进行了手册编制和试点测试(P50-DA09241)。这 干预措施的发展是为了认识到实质性的心理社会 滥用药物的母亲及其子女面临的风险，以及 值得注意的是，目前为成瘾者提供的育儿干预措施不足 有孩子的母亲已经过了婴儿期。基于发展的 心理病理学对复原力的看法，这种综合治疗 应对多个层面的逆境(个人、社区和家庭) 吸毒母亲面临的风险：通常导致负面结果的风险 父母教养方式与母亲心理社会苦恼的关系 随之而来的是，它们的后代出现了精神障碍。RPMG是一种 结构化治疗，每周24次，每组1个半小时 每个人。 在第一阶段研究中收集的初步数据证明了这一承诺 RPMG在不同的育儿行为和精神结果方面的作用 在母亲和她们的孩子中，在拟议的研究中，我们 寻求进行随机临床试验，将RPMG与 接受康复训练(RT；类似于标准药物的手动治疗 咨询)。RPMG和RT干预将作为补充提供 到美沙酮诊所定期提供的治疗。八十 服用美沙酮的母亲将随机接受这两种治疗 条件，产生的总样本量为160。多方法， 将获得多个信息者的评估，以衡量显著结果， 包括母亲和她们的孩子，以及母亲的 临床医生和孩子们的老师。 本研究将探讨以下具体目标：(1)至 从以下方面评估RPMG与RT的比较有效性 (A)中的改进母亲的育儿行为和态度，以及她们的 精神障碍；以及(B)在他们孩子的水平上 症状学和日常社交能力；要评估 RPMG治疗收益的持久性，以及潜在的延迟治疗 通过对母亲和儿童进行6个月的跟踪评估，影响 在RPMG治疗活跃期后；研究以下几种方式 特定的产妇特征关系到治疗的成功。指导原则 在之前的研究中，这些特征将包括(A)智力(b.) 感觉寻求(c.)种族；及(D)准备好接受治疗了。

DESCRIPTION: (Applicant's Abstract) The proposed study will involve a randomized clinical trial of the Relational Parenting Mothers' Group, (RPMG), an intervention designed for opioid abusing women with children less than 14 years of age, which was manualized and pilot tested as part of a Phase I study (P50-DA09241). This intervention was developed in recognition of the substantial psychosocial risks faced by substance abusing mothers and their offspring, and the notable lack of parenting interventions currently available for addicted mothers with children past the infancy years. Based on developmental psychopathology perspectives on resilience, this integrative treatment addresses multiple levels of adversity (individual, community, and family) faced by drug abusing mothers: risks that typically result in negative parenting behaviors and psychosocial distress among the mothers and concomitantly, psychiatric disturbance among their offspring. RPMG is a structured treatment, entailing 24 weekly group sessions of 1 1/2 hours each. Preliminary data collected in the Phase I study have attested to the promise of RPMG in terms of diverse parenting behaviors and psychiatric outcomes among both the mothers and their children, and in the proposed study, we seek to conduct a randomized clinical trial in which RPMG will be compared with Recovery Training (RT; a manualized treatment resembling standard drug counseling). Both RPMG and RT interventions will be offered as supplements to treatment regularly offered at the methadone clinics. Eighty methadon-maintained mothers will be randomized to each of the two treatment conditions, yielding a total sample size of 160. Multiple-method, multiple-informant assessments will be obtained to measure salient outcomes, including reports from the mothers and their children, and from the mothers' clinicians and the children's teachers. The following specific goals will be addressed within this study: (1.) To evaluate the comparative effectiveness of RPMG versus RT in terms of improvements in (a.) mothers' parenting behaviors and attitudes, and their psychiatric disturbance; as well as and (b.) in their children's levels of symptomatology and everyday social competence; (2.) To evaluate the durability of RPMG treatment gains, as well as potentially delayed treatment effects, via follow-up assessments of both mothers and children six months after the active phase of RPMG treatment; and (3.) To examine ways in which specific maternal characteristics relate to treatment success. Guided by previous research, these characteristics will include (a.) intelligence (b.) sensation seeking (c.) ethnicity; and (d.) readiness for treatment.